Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer.
about
The involvement of insulin-like growth factor 2 binding protein 3 (IMP3) in pancreatic cancer cell migration, invasion, and adhesionThe Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.Expression of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in sacral chordoma.Effects of LncRNA-HOST2 on cell proliferation, migration, invasion and apoptosis of human hepatocellular carcinoma cell line SMMC-7721Role of IGF2BP3 in trophoblast cell invasion and migrationERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFRPrognostic value of high IMP3 expression in solid tumors: a meta-analysisSomatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis.IMP3 expression is associated with epithelial-mesenchymal transition in breast cancer.Up-regulation of Imp3 confers in vivo tumorigenicity on murine osteosarcoma cells.Imp3 expression in benign and malignant thyroid tumors and hyperplastic nodulesEnhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma ProgressionA Novel Role for VICKZ Proteins in Maintaining Epithelial Integrity during Embryogenesis.Reciprocal Regulation of ERα and ERβ Stability and Activity by Diptoindonesin G.An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancerInsulin-like growth factor 2 mRNA binding protein 3 expression is an independent prognostic factor in pediatric pilocytic and pilomyxoid astrocytoma.Clear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression.Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function.Expression of the oncofetal protein IGF2BP3 in endometrial clear cell carcinoma: assessment of frequency and significance.IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer.IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis.EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression.LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b.Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation.IMP3 promotes stem-like properties in triple-negative breast cancer by regulating SLUG.ERβ1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer.A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard.BRCA-mutated Invasive Breast Carcinomas: Immunohistochemical Analysis of Insulin-like Growth Factor II mRNA-binding Protein (IMP3), Cytokeratin 8/18, and Cytokeratin 14.The H19-PEG10/IGF2BP3 axis promotes gastric cancer progression in patients with high lymph node ratios.RNA Binding Protein as an Emerging Therapeutic Target for Cancer Prevention and Treatment.Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) promotes lung tumorigenesis via attenuating p53 stability.IMP3 Is Strongly Expressed in Malignant Phyllodes Tumors of the Breast: An Immunohistochemical Study.
P2860
Q30641525-E25D4E16-8B07-4F20-8EA5-3CBD5730A57DQ30978083-3636FCAF-C4C7-4B14-A2D1-77E8EAFCB923Q33274978-22E1E510-9BB7-4D5A-B9BF-A436735B9CDBQ33583618-03823258-FC76-41E1-852A-381B5AAF2947Q33694962-B83376BC-8A3A-4D4A-AF7F-7A498275DDF7Q33739387-19AF6108-84E4-47EA-B19D-A686168FC025Q33813288-4B253557-7869-479D-93E2-04C7231E21D6Q33864656-7D57EC6D-19FB-4A36-BEF0-4AB7D4B2CA51Q33898581-CC769925-72E8-40BF-9E20-6C1603DDD60BQ34505648-E1DA2A22-608B-4522-9C78-994E4261C9F2Q35125481-A0D3FA94-19E3-4F93-9A61-E4105BF02229Q35546846-C9A3A7A2-3ADE-4F98-A33A-A9555891AB34Q35758571-BAF4B934-02E5-424B-8C7F-7FB73A8A726EQ35869243-20ED4BA5-5B0C-4383-B781-DAC3E5121DE3Q36315707-1E266DBB-10D7-450F-BE67-698A188434B3Q36377476-C4F6C3B2-4AA6-4824-BDC2-A91D4CA26AE1Q36529643-03B6FDF9-968D-4F1C-AFCF-DA579AB6F8C1Q37002361-F9FAE0BD-784B-4869-B65C-5EDF5A6DCA97Q37046414-8CB41DD4-B1A7-46F5-8CA0-12FA720D78AFQ37463112-769D55DE-5EF4-42CF-8E50-5B51CF3BE4A6Q37507920-DE8B0BD0-919F-497B-8BA9-3CA142114F56Q37747546-CBD68B51-550C-4113-B945-83B049ED30D0Q38834075-E636D2D6-164D-4465-B837-CEE146E93784Q38949919-FFA9F9EA-E74B-49F8-B630-8B956A45DDA0Q38969133-650C40DD-2EE7-463E-AC4F-515AB669BB2AQ40931217-264BC1F3-B3E3-4462-9610-F88AB440ADDEQ41674321-86568CAF-DB71-4618-8BF6-46389060B534Q42438922-64E3CE7F-0746-4BA4-B1B8-383A595D54E8Q42482668-BB4D08AA-1671-432A-8F20-FAA866E5D8DEQ46207048-43696BA6-3FA7-4CBB-AEAB-3CBFF62A359FQ47129433-5382FFFA-CCF7-4186-A10F-98F6593081F3Q47135760-1A229853-EB0E-4A3F-83B0-6159C694416FQ53351079-E4DDFA1A-7FEE-4F3A-9943-96569C5FF1B8
P2860
Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Regulation of IMP3 by EGFR sig ...... triple-negative breast cancer.
@ast
Regulation of IMP3 by EGFR sig ...... triple-negative breast cancer.
@en
type
label
Regulation of IMP3 by EGFR sig ...... triple-negative breast cancer.
@ast
Regulation of IMP3 by EGFR sig ...... triple-negative breast cancer.
@en
prefLabel
Regulation of IMP3 by EGFR sig ...... triple-negative breast cancer.
@ast
Regulation of IMP3 by EGFR sig ...... triple-negative breast cancer.
@en
P2093
P2860
P356
P1433
P1476
Regulation of IMP3 by EGFR sig ...... triple-negative breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2011.620
P407
P577
2012-01-23T00:00:00Z